Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 235 for “"warfarin"”.

  1. Medication-Related Problems in Older Adults: A Focus on Underuse of Warfarin and Warfarin-Antibiotic Interactions

    … with respect to a high-risk medication such as warfarin. Warfarin is a challenge to use in clinical practice due to its narrow therapeutic index, variability in dose-response and its interactions with numerous foods and drugs. This dissertation presents the research from two projects. In the …

    vcu Repository record for Medication-Related Problems in Older Adults: A Focus on Underuse of Warfarin and Warfarin-Antibiotic Interactions (opens in a new tab)

  2. Warfarin use and risk of osteoporotic fractures

    … Prior studies examining the association of warfarin use and osteoporotic fractures have found conflicting results and have had methodological problems, such as confounding by indication and confounding by duration of warfarin use. Thus, we studied the association of warfarin use with …

    bu Repository record for Warfarin use and risk of osteoporotic fractures (opens in a new tab) Embargoed until 2999-01-01

  3. The pharmacogenomics of warfarin safety and effectiveness in children

    Use of the anticoagulant warfarin for thromboembolic disease prophylaxis is limited by a large inter - patient dose variability and high risk of adverse drug reactions (ADRs). Polymorphisms in two genes , CYP2C9 and VK ORC1 , have consistently been shown to be associated with warfar in dose …

    ubc Repository record for The pharmacogenomics of warfarin safety and effectiveness in children (opens in a new tab) Download PDF for The pharmacogenomics of warfarin safety and effectiveness in children (opens in a new tab)

  4. Validation of Criteria Used to Predict Warfarin Dosing Decisions

    … clots are often treated with anticoagulants, warfarin is such an anticoagulant. The dose's effect is measured by comparing the time for blood to clot to a control time called an INR value. Previous anticoagulant studies have addressed agreement between fingerstick (POC) devices and the …

    byu Repository record for Validation of Criteria Used to Predict Warfarin Dosing Decisions (opens in a new tab) Download PDF for Validation of Criteria Used to Predict Warfarin Dosing Decisions (opens in a new tab)

  5. Examining relationships between long non-coding RNA and warfarin pharmacogenes

    Inter-individual variability in warfarin metabolism and response is influenced by multiple factors, including genetic variations in important pharmacogenes such as VKORC1 and CYP2C9. LncRNA (long non-coding RNA) plays roles in diverse cellular processes including gene regulation. This study …

    washington Repository record for Examining relationships between long non-coding RNA and warfarin pharmacogenes (opens in a new tab)

  6. PREDICTION OF OPTIMAL WARFARIN MAINTENANCE DOSE USING ADVANCED ARTIFICIAL NEURAL NETWORKS

    … 377 patients (186 m; 191 f) treated with a VKA (warfarin) average weekly maintenance dose (WMD) of 23.7 mg (11.5 SD) were used to create a dose algorithm. Forty-eight variables, including demographic, clinical and genetic data (5 CYP2C9 and 3 VKORC1 genetic variants) were entered into Twist® …

    milano Repository record for PREDICTION OF OPTIMAL WARFARIN MAINTENANCE DOSE USING ADVANCED ARTIFICIAL NEURAL NETWORKS (opens in a new tab)

  7. In vitro metabolic drug interaction study of warfarin with sildenafil citrate

    … the in vitro metabolic drug interaction of warfarin and sildenafil in rat and human liver microsomes, and to evaluate the extent to which the in vitro data is predictive of the actual pharmacokinetic interaction between warfarin and sildenafil observed in vivo. Sildenafil inhibits on the …

    nus Repository record for In vitro metabolic drug interaction study of warfarin with sildenafil citrate (opens in a new tab) Download file for In vitro metabolic drug interaction study of warfarin with sildenafil citrate (opens in a new tab)

  8. The Impact of R10-Hydroxywarfarin on CYP2C9-Mediated S-Warfarin Metabolism

    Warfarin therapy is highly effective in treating both atrial fibrillation and deep vein thrombosis. Currently, more than 20 million Americans are receiving warfarin therapy. However, increased risk of adverse events are associated with both under and overdosing the drug. Sub–therapeutic plasma …

    washington Repository record for The Impact of R10-Hydroxywarfarin on CYP2C9-Mediated S-Warfarin Metabolism (opens in a new tab)

  9. Pharmacogenetic, clinical and demographic factors in the management of warfarin therapy.

    … in the U.K. are taking the anticoagulant drug warfarin, for the treatment or prevention of venous thromboembolism. The incidence of life threatening haemorrhage, due to overdose, is approximately two per one hundred patient years. It is well known that there is great inter-individual …

    sheffield-hallam Download PDF for Pharmacogenetic, clinical and demographic factors in the management of warfarin therapy. (opens in a new tab)

  10. Methods to Predict Individualized Combined Benefit/Harm Patient Profiles for Warfarin

    Warfarin has well-proven benefit (stroke prevention) but an associated increase in harm (major bleeding) in patients with atrial fibrillation (AF). Current clinical prediction rules (CPRs) are limited in that stroke CPRs predict only the probabilities of “stroke” and “no stroke” and bleeding CPRs …

    toronto-retro Repository record for Methods to Predict Individualized Combined Benefit/Harm Patient Profiles for Warfarin (opens in a new tab)

  11. Prevalence of drug-drug interactions of warfarin prescriptions in South Africa

    Background: Warfarin is an anticoagulant that is used for the prophylactic and therapeutic treatment for a wide range of thrombo-embolic disorders. The prescribing and monitoring of warfarin therapy is challenging due to the fact that warfarin exhibits numerous interactions with other drugs and a …

    nwu-za Repository record for Prevalence of drug-drug interactions of warfarin prescriptions in South Africa (opens in a new tab)

  12. The production, characterisation and applications of polyclonal and monoclonal antibodies to warfarin

    … of polyclonal and monoclonal antibodies to warfarin, an anticoagulant used in the management of a variety of thromboembolic disorders. 4'-nitrowarfarin was initially reduced in the presence of zinc and dilute acetic acid to 4'- aminowarfarin, which was characterised by a combination of …

    dcu Download PDF for The production, characterisation and applications of polyclonal and monoclonal antibodies to warfarin (opens in a new tab)

  13. Effects of high and low dose warfarin sodium on implanted spontaneous CΓéâH

    … we decided to investigate the relationship of warfarin sodium anticoagulation with tumor growth and vascularization. It was reasoned that if the previously observed altered tumor growth was due the heparin’s anticoagulant effect rather than a direct effect upon the tumor, another anticoagulant …

    u-pacific Repository record for Effects of high and low dose warfarin sodium on implanted spontaneous CΓéâH (opens in a new tab)

  14. Adaptive personalized drug delivery method for warfarin and anemia management: Modeling and control.

    … proposed methodology is applied to anemia and warfarin management. It is challenging in practice to achieve an optimal dosage of erythropoietin (EPO) to maintain Hemoglobin (Hgb) levels between 10-12 $g/dl$ in case of anemia management and the optimal dosage of warfarin to maintain an …

    louisville Repository record for Adaptive personalized drug delivery method for warfarin and anemia management: Modeling and control. (opens in a new tab)

  15. Severe renal dysfunction among individuals taking warfarin and implications for new oral anticoagulants

    … oral anticoagulants. METHODS: Patients taking warfarin for atrial fibrillation (AF) or venous thromboembolism (VTE) were consecutively enrolled from January 2007 to December 2010. Baseline kidney function was assessed and patients were followed to their first decline in Glomerular Filtration …

    bu Repository record for Severe renal dysfunction among individuals taking warfarin and implications for new oral anticoagulants (opens in a new tab) Embargoed until 2999-01-01

  16. Improving Warfarin dosing by applying machine learning to a small African data set

    Warfarin remains the mainstay of anticoagulants in sub-Saharan Africa (SSA). The dose of Warfarin is critical to providing a therapeutic effect without the potentially devastating side effects of thrombotic complications such as strokes, Deep Vein Thrombosis or Pulmonary Embolism associated with …

    cape-town Repository record for Improving Warfarin dosing by applying machine learning to a small African data set (opens in a new tab)

  17. Prediction in Therapeutic Effectiveness Research: Prolonged Dose Titration in Warfarin Patients and Model Transportability

    … examine the specific case of patients starting warfarin therapy, many of whom are at higher risk of bleeding and thrombotic events because they take a long time to determine their optimal therapeutic dose. Additionally, we examine the general problem of transportability of clinical prediction …

    penn Repository record for Prediction in Therapeutic Effectiveness Research: Prolonged Dose Titration in Warfarin Patients and Model Transportability (opens in a new tab)

Page 1 of 12